Lisa McKerracher

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada.

KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada.

The McKnight Endowment Fund for Neuroscience operates as a philanthropic organization. Its services include grantmaking, coalition-building and encouragement of strategic policy reforms. The company was founded by William L. McKnight in 1989 and is headquartered in Minneapolis, MN.

Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada.

Aptus Health, Inc. operates a marketing platform for physicians and health care professionals. Its services include Geo-targeting mobile advertising; clinical alerts and eNewsletters; insight and attitudinal surveys; KOL-led presentations; eDetails; Peer-to-Peer collaboration; eSampling; Electronic Health Record integration; patient feedback; segmentation and tartgeting; behavioral insights; and intelligence and reporting. The company was founded by Donato J. Tramuto in 2008 and is headquartered in Reading, MA.

Novartis Korea Ltd. engages in the manufacture and sale of pharmaceutical products. The company was founded on September 20, 1984 and is headquartered in Seoul, South Korea.

AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany.

LUMA Capital LLC provides investment advice. The private company is based in Naples, FL. The company was founded by Luc Mainville.

Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada.